FMR LLC reports 9.7% stake in QuidelOrtho
QuidelOrtho Corp was reported as having 6,591,151.54 shares beneficially owned by FMR LLC, representing 9.7% of the common stock as of 03/31/2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
QuidelOrtho Corp was reported as having 6,591,151.54 shares beneficially owned by FMR LLC, representing 9.7% of the common stock as of 03/31/2026. The filing (Schedule 13G/A Amendment No. 2) lists sole dispositive power of 6,591,151.54 shares and sole voting power of 6,587,889 shares. The cover shows CUSIP 219798105 and identifies Abigail P. Johnson in a related reporting capacity.
Insights
FMR LLC holds a disclosed passive stake of 9.7% in QuidelOrtho as of 03/31/2026.
FMR LLC is reported with 6,591,151.54 shares of beneficial ownership and sole dispositive power over the same amount, indicating control over disposition decisions. The filing is an amendment to a Schedule 13G, a routine passive ownership disclosure under Section 13.
Key dependencies include any future amendments or Schedule 13D conversion if the position becomes active. Subsequent filings would show changes in percentage or voting/dispositive power.
Key Figures
Key Terms
Schedule 13G/A regulatory
Beneficially owned financial
Sole dispositive power regulatory
Power of Attorney legal
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does FMR LLC report in QDEL?
What form was filed for this disclosure on QDEL?
Does the filing identify any other persons with >5% interest in QDEL?
Who signed the Schedule 13G/A amendment for FMR LLC?
AI-generated analysis. How Rhea-AI works. Not financial advice.